OBJECTIVE: To determine the effects of formatting alternatives in Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence profiles on guideline panelists' preferences, comprehension, and accessibility. STUDY DESIGN AND SETTING: We randomized 116 antithrombotic therapy guideline panelists to review one of two table formats with four formatting alternatives. After answering relevant questions, panelists reviewed the other format and reported their preferences for specific formatting alternatives. RESULTS: Panelists (88 of 116 invited [76%]) preferred presentation of study event rates over no study event rates (median 1 [interquartile range (IQR) 1] on 1-7 scale), absolute risk differences over absolute risks (median 2 [IQR 3]), and additional information in table cells over footnotes (median 1 [IQR 2]). Panelists presented with time frame information in the tables, and not only in footnotes, were more likely to correctly answer questions regarding time frame (58% vs. 11%, P<0.0001), and those presented with risk differences and not absolute risks were more likely to correctly interpret confidence intervals for absolute effects (95% vs. 54%, P<0.0001). Information was considered easy to find, easy to comprehend, and helpful in making recommendations regardless of table format (median 6, IQR 0-1). CONCLUSION: Panelists found information in GRADE evidence profiles accessible. Correct comprehension of some key information was improved by providing additional information in table and presenting risk differences.
RCT Entities:
OBJECTIVE: To determine the effects of formatting alternatives in Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence profiles on guideline panelists' preferences, comprehension, and accessibility. STUDY DESIGN AND SETTING: We randomized 116 antithrombotic therapy guideline panelists to review one of two table formats with four formatting alternatives. After answering relevant questions, panelists reviewed the other format and reported their preferences for specific formatting alternatives. RESULTS: Panelists (88 of 116 invited [76%]) preferred presentation of study event rates over no study event rates (median 1 [interquartile range (IQR) 1] on 1-7 scale), absolute risk differences over absolute risks (median 2 [IQR 3]), and additional information in table cells over footnotes (median 1 [IQR 2]). Panelists presented with time frame information in the tables, and not only in footnotes, were more likely to correctly answer questions regarding time frame (58% vs. 11%, P<0.0001), and those presented with risk differences and not absolute risks were more likely to correctly interpret confidence intervals for absolute effects (95% vs. 54%, P<0.0001). Information was considered easy to find, easy to comprehend, and helpful in making recommendations regardless of table format (median 6, IQR 0-1). CONCLUSION: Panelists found information in GRADE evidence profiles accessible. Correct comprehension of some key information was improved by providing additional information in table and presenting risk differences.
Authors: Benoît Béchard; Joachim Kimmerle; Justin Lawarée; Pierre-Oliver Bédard; Sharon E Straus; Mathieu Ouimet Journal: Int J Environ Res Public Health Date: 2022-05-20 Impact factor: 4.614
Authors: Alonso Carrasco-Labra; Romina Brignardello-Petersen; Nancy Santesso; Ignacio Neumann; Reem A Mustafa; Lawrence Mbuagbaw; Itziar Etxeandia Ikobaltzeta; Catherine De Stio; Lauren J McCullagh; Pablo Alonso-Coello; Joerg J Meerpohl; Per Olav Vandvik; Jan L Brozek; Elie A Akl; Patrick Bossuyt; Rachel Churchill; Claire Glenton; Sarah Rosenbaum; Peter Tugwell; Vivian Welch; Gordon Guyatt; Holger Schünemann Journal: Trials Date: 2015-04-16 Impact factor: 2.279
Authors: Jennifer Petkovic; Vivian Welch; Maria Helena Jacob; Manosila Yoganathan; Ana Patricia Ayala; Heather Cunningham; Peter Tugwell Journal: Implement Sci Date: 2016-12-09 Impact factor: 7.327
Authors: Juan José Yepes-Nuñez; Rebecca L Morgan; Lawrence Mbuagbaw; Alonso Carrasco-Labra; Stephanie Chang; Susanne Hempel; Paul Shekelle; Mark Helfand; Tejan Baldeh; Holger J Schünemann Journal: BMJ Open Date: 2018-01-23 Impact factor: 2.692
Authors: Shaun Treweek; Andrew D Oxman; Philip Alderson; Patrick M Bossuyt; Linn Brandt; Jan Brożek; Marina Davoli; Signe Flottorp; Robin Harbour; Suzanne Hill; Alessandro Liberati; Helena Liira; Holger J Schünemann; Sarah Rosenbaum; Judith Thornton; Per Olav Vandvik; Pablo Alonso-Coello Journal: Implement Sci Date: 2013-01-09 Impact factor: 7.327
Authors: Paul Garner; Sally Hopewell; Jackie Chandler; Harriet MacLehose; Holger J Schünemann; Elie A Akl; Joseph Beyene; Stephanie Chang; Rachel Churchill; Karin Dearness; Gordon Guyatt; Carol Lefebvre; Beth Liles; Rachel Marshall; Laura Martínez García; Chris Mavergames; Mona Nasser; Amir Qaseem; Margaret Sampson; Karla Soares-Weiser; Yemisi Takwoingi; Lehana Thabane; Marialena Trivella; Peter Tugwell; Emma Welsh; Ed C Wilson; Holger J Schünemann Journal: BMJ Date: 2016-07-20
Authors: Rebecca Woodhouse; Matthew Neilson; Marrissa Martyn-St James; Julie Glanville; Catherine Hewitt; Amanda E Perry Journal: Health Justice Date: 2016-09-13